Agree on the volatility risks. Flip side is, if one pulls out entirely, there is the risk of missing out on possibly an even greater run.
As for price, what matters is what people are willing to pay to get in, and at what level will they hold/sell/buy more - it did touch $17 today. These decisions will be based on what shareholders think of the tech and its future value, not entirely on present day market cap.
You may see the new money as 'fool's money' or late-hoppers onto the bandwagon, and perhaps you're right. My sense is that the new money (and its really not that much at this point) is coming largely from the medical community (that's how I first heard about it), who are reading up on & sharing amongst themselves what may be a game-changer in a large market (doesn't get much bigger than heart disease). If so, what we see now is just the beginning.
Your play is probably smarter - a 30+% retrace is a more logical guess than a 30+% additional gain. As you say, its illiquidity makes this a fast moving target, up or down.
I got into this as NILE @ .03, and considered it a 'see where its at in 3-5 years' type of investment. Never did I expect to be up 900% in just a few months. That forces me to make decisions, and I appreciate that you are willing to share your strategies here.
If you turn out to be right, this 'slaughtered' hog will congratulate you on your foresight.
News 
Market Data 
Discover 
